Skip to main content


Fig. 3 | Clinical and Translational Medicine

Fig. 3

From: RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR

Fig. 3

The activation of EGFR by RANKL depends on the existence of Cav-1. a The gastric cancer cells were treated with RANKL (1 μg/ml) for the indicated times by Western blot, the level of p-Cav-1 increased significantly, BGC-823 for 15 min and SGC-7901 for 45 min. b While we knocked down of Cav-1 gene by using Cav-1 siRNAs for 72 h, Cav-1 and P-Cav-1 decreased significantly, P-EGFR also decreased significantly

Back to article page